I have four totally uninformed thoughts about extension requests, all of which are based on wild ignorant speculation:
Agreed
Otherwise here is the BLU asking for extension. I converted it from PDF publicly posted to FDA to ASCII. It also asks for 75 days added, others I have seen were asking for 105 to get to 180 total, making me wonder if 75 extension is a number being picked for a reason.
The BLU version is really only addressing E-Cigs and cites examples of Regs it quotes, so it could be a better template than SFATA's very very generic template..
As follows:
Re: Request for Extension of Comment Period: Docket No. FDA-2014-N-0189-0001; Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act
Lorillard Tobacco Company (Lorillard) respectfully requests that the Food and Drug Administration (FDA) extend by 75 days the comment period for its Proposed Rule, Deeming Tobacco Products To Be Su bject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Famil y Smok ing Prevention and Tobacco Cont rol Act, Docket No. FDA-2014-N-0189-000 I , for a total of 150 days. As further explained below, the additional time is necessary to appropriatel y ana l yze and research the Proposed Rule, i ts lengthy and extensi ve Preamble, and the references relied upon by the FDA within the Proposed Rule and Preamble released by FDA to compile responsive comments to address the issues raised by FDA in its publication.
I. Proposal Involved and Action Requested
Pursuant to 21 C.F.R. § 10.40, Lorillard seeks a 75-day extension of the comment period for FDA 's Proposed Ru le, Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Famil y Smoking Prevention and Tobacco Control Act. The Proposed Rule was published in the Federal Register on April 25, 2014, and it was requested that comments be submitted to FDA by July 9, 2014.1 Lori liard 's request for an extension of 75 days for a total of 150 days would allow for comments to be submitted until September 22,2014.
II. Statement of Grounds
Lorillard is diligently working to prepare comments to FDA's Proposed Rule, and specifica ll y the Preamble to the Proposed Rule, but believes that an extension of the comment period is warranted. First, Lorillard and interested parties should be allowed sufficient time to analyze the scientific content of the Proposed Rule and its Preamble that FDA made publicly available. This document consists of 241 pages, including information regarding Continuum of Nicotine. Delivering Products, Public Health Benefits of Deeming, Addictive Nature of Products, and Health Risks of Products. FDA has relied upon, or made reference to, 194 references within its Proposed Rule and Preamble. Due to the voluminous nature of the reference material within the FDA Proposed Rule and Preamble, ample time will be required to allow Lorillard and all other interested parties to analyze the cited material and make comment based upon its interpretation and analysis of the materials. Extension of the comment period for a reasonable 75 additional days is thus appropriate, and will better allow Lorillard and other interested parties to analyze the agency's Proposed Rule and Preamble, including the numerous references upon which FDA has relied.
Second, FDA has requested comment to various topics within the Preamble to the Proposed Rule, including a Request for Comments Regarding Scope, Request for Comments Regarding Regulation of E-Cigarettes and Request for Comments Regarding Components, Parts and Accessories. Specifically, FDA has requested research and data regarding e-cigarettes. Lorillard is in the process of conducting, concluding and publishing the results of several studies pertaining to the use of e-cigarettes and the toxicology of the product. Lorillard desires to provide FDA with the results of these studies to aid FDA with their objective to gather science, research and data and to help further FDA's task of promulgating science-based regulations. However, Lorillard needs sufficient time to conclude the studies, analyze the data from the studies and publish the data in a manner which will aid FDA. Extension of the comment period for 75 additional days is thus reasonable, and will better allow Lorillard to complete these studies and publish accurate data.
In sum, a 75-day extension of the comment period is a reasonable request and will support development of a more complete administrative record to assist FDA in making a science-based determination regarding any regulation of deemed tobacco products. Lorillard therefore respectfully requests that FDA extend the comment period for the Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act for 150 days, to September 22, 2014.
1 See 79 Fed. Reg. 23,142 (A p r. 25, 201 4).